These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35521355)

  • 21. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma.
    Liu C; Tong Z; Tan J; Xin Z; Wang Z; Tian L
    Exp Ther Med; 2019 Nov; 18(5):3543-3551. PubMed ID: 31602231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression.
    Li X; Rui B; Cao Y; Gong X; Li H
    Oncol Lett; 2020 Mar; 19(3):2035-2042. PubMed ID: 32194700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of concern: Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway.
    Fisher L
    RSC Adv; 2022 Feb; 12(8):4777. PubMed ID: 35427076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA CCAT1 knockdown suppresses tongue squamous cell carcinoma progression by inhibiting the ubiquitination of PHLPP2.
    Liu F; Yang H; Liu X; Ning Y; Wu Y; Yan X; Zheng H; Liu C
    Mol Cell Biochem; 2024 May; ():. PubMed ID: 38763996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.
    Jia LF; Huang YP; Zheng YF; Lyu MY; Wei SB; Meng Z; Gan YH
    Oral Oncol; 2014 Nov; 50(11):1062-71. PubMed ID: 25127200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma.
    Zhou G; Huang Z; Meng Y; Jin T; Liang Y; Zhang B
    J Oral Pathol Med; 2020 Nov; 49(10):1011-1018. PubMed ID: 32531865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
    Sun XH; Fan WJ; An ZJ; Sun Y
    Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.
    Zhu Y; Li B; Xu G; Han C; Xing G
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34633056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
    Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
    Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA CRNDE may be associated with poor prognosis by promoting proliferation and inhibiting apoptosis of cervical cancer cells through targeting PI3K/AKT.
    Yang HY; Huang CP; Cao MM; Wang YF; Liu Y
    Neoplasma; 2018 Nov; 65(6):872-880. PubMed ID: 30334449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA CASC9 Affects Cell Proliferation, Migration, and Invasion of Tongue Squamous cell Carcinoma via Regulating miR-423-5p/SOX12 Axes.
    Chen X; Xu H; Sun G; Zhang Y
    Cancer Manag Res; 2020; 12():277-287. PubMed ID: 32021442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.
    Ren L; Yang S; Cao Q; Tian J
    Onco Targets Ther; 2021; 14():355-366. PubMed ID: 33469312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of Notch2 drives tongue squamous cell carcinoma carcinogenesis.
    Gan RH; Lin LS; Zheng DP; Zhao Y; Ding LC; Zheng DL; Lu YG
    Exp Cell Res; 2021 Feb; 399(1):112452. PubMed ID: 33382997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 Axis.
    Liu C; Hou J; Shan F; Wang L; Lu H; Ren T
    Onco Targets Ther; 2020; 13():4931-4942. PubMed ID: 32581554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.